Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1+17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| MPP dihydrochloride (289726-02-9 Free base) | C29H32ClN3O3 | 911295-24-4 | Details |
| mPGES1-IN-3 | C24H16ClF5N4O3 | 1469976-70-2 | Details |
| Sodium etidronate；Didronel | C2H9NaO7P2 | 7414-83-7 | Details |
| Mocravimod hydrochloride；KRP-203 | C24H27Cl2NO3S | 509088-69-1 | Details |
| Monobehenin | C25H50O4 | 30233-64-8 | Details |
| Morphothiadin | C21H22BrFN4O3S | 1092970-12-1 | Details |
| Mps1-IN-1 | C28H33N5O4S | 1125593-20-5 | Details |
| MR-L2 | C19H16Cl3FN4O | 2374703-19-0 | Details |
| MOZ-IN-2 | C17H13FN4O3S | 2055397-88-9 | Details |
| Monomethyl fumarate | C5H6O4 | 2756-87-8 | Details |
| Monacolin J | C19H28O4 | 79952-42-4 | Details |
| Monascin | C21H26O5 | 21516-68-7 | Details |
| Morinidazole (R enantiomer)；R-Morinidazole | C11H18N4O4 | 898230-59-6 | Details |
| Morinidazole | C11H18N4O4 | 92478-27-8 | Details |
| MRGPRX1 agonist 1 | C23H21N3O4S | 2377379-39-8 | Details |
| Modecainide；BMY 40327;MJ 14030 | C22H28N2O3 | 81329-71-7 | Details |
| MN58b | C32H40BrN4+ | 203192-01-2 | Details |
| MRK-016 | C17H20N8O2 | 342652-67-9 | Details |
| MS31 | C20H27N3O2 | 2366264-12-0 | Details |
| MPDC | C7H9NO4 | 159262-32-5 | Details |
| MS402 | C20H19ClN2O3 | 1672684-68-2 | Details |
| MS645 | C48H54Cl2N10O2S2 | 2250091-96-2 | Details |
| Flunixin meglumine | C14H11F3N2O2.C7H17NO5 | 42461-84-7 | Details |
| Mogroside I E1 | C36H62O9 | 88901-39-7 | Details |
| Mogroside I A1 | C36H62O9 | 88901-46-6 | Details |
| Mofegiline hydrochloride；MDL72974A | C11H13F2N.ClH | 120635-25-8 | Details |
| MRZ 2-514；8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one | C11H6BrN3O3 | 202808-11-5 | Details |
| Levosulpiride；S-(-)-Sulpiride;RV-12309 | C15H23N3O4S | 23672-07-3 | Details |
| MRT-83 | C31H30N4O5 | 1263131-92-5 | Details |
| MM-589 TFA | 2097887-21-1 | Details |
| MM-589 | C28H44N8O5 | 2097887-20-0 | Details |
| Mycophenolic acid-d3；Mycophenolate D3;Mycophenolic acid D3 | C17H20O6 | 1185242-90-3 | Details |
| Mutated EGFR-IN-3 | C31H29FN4O2 | 2375107-27-8 | Details |
| MYCi361 | C26H16ClF9N2O2 | 2289690-31-7 | Details |
| N-(3-Methoxybenzyl)Palmitamide | C24H41NO2 | 847361-96-0 | Details |
| Ribostamycin sulfate | C17H36N4O14S | 53797-35-6 | Details |
| MT-7716 free base；W-212393 | C27H28N4O2 | 610323-32-5 | Details |
| MT-7716 hydrochloride；W-212393 hydrochloride | C27H29ClN4O2 | 1215859-93-0 | Details |
| Ketorolac tromethamine salt；Ketorolac tris salt;Acular;Acular LS;Toradol | C19H24N2O6 | 74103-07-4 | Details |
| MT-3014 | C23H25F2N7O | 1332727-40-8 | Details |
| MSOP | C4H10NO6P | 66515-29-5 | Details |
| MtbHU-IN-1 | C44H36N4O12S2 | 59736-84-4 | Details |
| Mutant IDH1-IN-4 | C25H34N4O3 | 1416270-18-2 | Details |
| Mutated EGFR-IN-2 | C29H35FN8O3 | 2050906-97-1 | Details |
| MYCMI-6 | C20H19N7O | 681282-09-7 | Details |
| mTOR inhibitor-3 | C25H30N8O2 | 1207358-59-5 | Details |
| N-Caffeoyl O-methyltyramine | C18H19NO4 | 189307-47-9 | Details |
| N-Acetyl-Calicheamicin | C57H76IN3O22S4 | 108212-76-6 | Details |
| Nicardipine hydrochloride | C26H30ClN3O6 | 54527-84-3 | Details |
| N-Desethyl amodiaquine dihydrochloride | C18H20Cl3N3O | 79049-30-2 | Details |
| ETA antagonist 1 | C20H25N3O3S | 161801-60-1 | Details |
| N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea | C13H12ClN3O | 97627-24-2 | Details |
| N6-(4-Hydroxybenzyl)adenosine | C17H19N5O5 | 110505-75-4 | Details |
| mTOR inhibitor-2 | C23H21N7O | 2219323-96-1 | Details |
| N6-Cyclohexyladenosine | C16H23N5O4 | 36396-99-3 | Details |
| nAChR agonist 1 | C20H18ClNO3S2 | 1394371-75-5 | Details |
| N6-(2-Phenylethyl)adenosine | C18H21N5O4 | 20125-39-7 | Details |
| N6-Methyladenosine 5'-monophosphate disodium salt | C11H14N5Na2O7P | 81921-35-9 | Details |
| N-Me-L-Ala-maytansinol | C32H44ClN3O9 | 77668-69-0 | Details |
| N-Desmethyltamoxifen | C25H27NO | 31750-48-8 | Details |
| N-Methylmoranoline；MOR 14;N-Methyl-1-deoxynojirimycin;N-Methylmoranolin | C7H15NO4 | 69567-10-8 | Details |
| MTH1-IN-2 | C24H27N3O5S | 901044-91-5 | Details |
| N-type calcium channel blocker-1 | C31H47N3 | 241499-17-2 | Details |
| N-Desethyl amodiaquine | C18H18ClN3O | 79352-78-6 | Details |
| Y1 receptor antagonist 1；H 409-22 isomer | C28H33N5O3 | 221697-09-2 | Details |
| Naloxone benzoylhydrazone；NalBzoH | C26H27N3O4 | 119630-94-3 | Details |
| Nadolol-d9；Nadolol D9;SQ-11725 D9 | C17H27NO4 | 94513-92-5 | Details |
| 9-Propenyladenine；Tenofovir Impurity 2;Mutagenic Impurity of Tenofovir Disoproxil | C8H9N5 | 1446486-33-4 | Details |
| MUT056399 | C15H13F2NO3 | 1269055-85-7 | Details |
| MuRF1-IN-1 | C18H15N3O3 | 445222-91-3 | Details |
| Naminterol | C19H26N2O3 | 93047-40-6 | Details |
| N-Desmethyltamoxifen hydrochloride | C25H27NO.ClH | 15917-65-4 | Details |
| Butenafine hydrochloride | C23H27N.ClH | 101827-46-7 | Details |
| Nacubactam | C9H16N4O7S | 1452458-86-4 | Details |
| Diethylstilbestrol | C18H20O2 | 56-53-1 | Details |
| APNEA | C18H22N6O4 | 89705-21-5 | Details |
| N-0861 racemate | C13H17N5 | 121241-87-0 | Details |
| Naltrindole hydrochloride | C26H27ClN2O3 | 111469-81-9 | Details |
| Nampt-IN-5 | C25H25N5O2 | 2380013-17-0 | Details |
| N3PT；N3-pyridyl thiamine | C13H19Cl2N3OS | 13860-66-7 | Details |
| N-Methylbenzamide | C8H9NO | 613-93-4 | Details |
| N6-Ethyladenosine | C12H17N5O4 | 14357-08-5 | Details |
| N-piperidine Ibrutinib hydrochloride | C22H23ClN6O | 2231747-18-3 | Details |
| N-Desmethyl Clomipramine hydrochloride；Desmethylclomipramine hydrochloride | C18H22Cl2N2 | 29854-14-6 | Details |
| N-Desethyl Oxybutynin-d5 hydrochloride；N-Desethyl Oxybutynin D5 hydrochloride | C20H28ClNO3 | 1173018-49-9 | Details |
| N-Desethyl Sunitinib；SU-11662 | C20H23FN4O2 | 356068-97-8 | Details |
| Mutant IDH1-IN-2 | C24H31F2N5O2 | 1429176-69-1 | Details |
| N-Desmethyl-Apalutamide | C20H13F4N5O2S | 1332391-11-3 | Details |
| N-(2-Hydroxypropyl)methacrylamide | C7H13NO2 | 21442-01-3 | Details |
| Piperacillin sodium | C23H26N5NaO7S | 59703-84-3 | Details |
| N-(3-Hydroxytetradecanoyl)-DL-homoserine lactone；N-(3-oxodecanoyl)-homoserine lactone | C18H33NO4 | 172670-99-4 | Details |
| N-deacetylated BMS-202 | C23H27N3O2 | 2310135-18-1 | Details |
| N-Boc-Val-Dil-Dap-Doe | C40H63N5O7S | 135383-62-9 | Details |
| MSC2360844 | C26H27FN4O5S | 1305267-37-1 | Details |
| MSC1094308 | C29H29F3N2 | 2219320-08-6 | Details |
| MSI-1436；Aminosterol-1436;Trodusquemine | C37H72N4O5S | 186139-09-3 | Details |
| MSI-1701 | C37H72N4O5S | 390808-64-7 | Details |
| MSI-1436 lactate；Trodusquemine lactate;Aminosterol-1436 lactate | C40H78N4O8S | 1309370-86-2 | Details |
| MRS-3777 hemioxalate | C19H21N5O5 | 1186195-57-2 | Details |
| MRS1845 | C21H22N2O6 | 544478-19-5 | Details |
| Product Total： Product Page： | ||||
| 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 | ||||